Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.
Altmann DM, Reynolds CJ, Joy G, Otter AD, Gibbons JM, Pade C, Swadling L, Maini MK, Brooks T, Semper A, McKnight Á, Noursadeghi M, Manisty C, Treibel TA, Moon JC; COVIDsortium investigators; Boyton RJ.
Altmann DM, et al.
Nat Commun. 2023 Aug 23;14(1):5139. doi: 10.1038/s41467-023-40460-1.
Nat Commun. 2023.
PMID: 37612310
Free PMC article.